aloxistatin has been researched along with Neoplasm Metastasis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creighton, CJ; Fradette, JJ; Gibbons, DL; Gibson, LA; Grzeskowiak, CL; Kundu, ST; Rodriguez, LB; Scott, KL | 1 |
Ahsan, A; Bain, DL; Ostrowski, LE; Pagast, P; Patel, A; Schultz, RM; Suthar, BP; Wong, C | 1 |
2 other study(ies) available for aloxistatin and Neoplasm Metastasis
Article | Year |
---|---|
TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins.
Topics: Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Calcium; Cathepsins; Cell Line, Tumor; Cysteine Proteinase Inhibitors; Exocytosis; Gene Expression Regulation, Neoplastic; Humans; Leucine; Lung Neoplasms; Lysosomes; Membrane Proteins; Mice; Neoplasm Metastasis; Nerve Tissue Proteins; Prognosis; Protein Isoforms; Proteolysis; Signal Transduction; Survival Analysis; Xenograft Model Antitumor Assays | 2018 |
Selective inhibition of proteolytic enzymes in an in vivo mouse model for experimental metastasis.
Topics: Animals; Cathepsin B; Cathepsins; Cysteine Endopeptidases; Dose-Response Relationship, Drug; Endopeptidases; Female; Fibrinolysis; Leucine; Leupeptins; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Peptide Hydrolases; Plasminogen Activators; Plasminogen Inactivators; Protease Inhibitors; Serine Endopeptidases; Thrombin; Thrombosis | 1986 |